Related references
Note: Only part of the references are listed.Resveratrol Prevents the Development of Pathological Cardiac Hypertrophy and Contractile Dysfunction in the SHR Without Lowering Blood Pressure
Sijo J. Thandapilly et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes
Agnieszka Biala et al.
BLOOD PRESSURE (2010)
SirT1 in muscle physiology and disease: lessons from mouse models
Manlio Vinciguerra et al.
DISEASE MODELS & MECHANISMS (2010)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Resveratrol Arrests and Regresses the Development of Pressure Overload- but Not Volume Overload-Induced Cardiac Hypertrophy in Rats
Peter Wojciechowski et al.
JOURNAL OF NUTRITION (2010)
Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation
Aparna Purushotham et al.
CELL METABOLISM (2009)
Overexpression of SIRT1 Protects Pancreatic β-Cells Against Cytokine Toxicity by Suppressing the Nuclear Factor-κB Signaling Pathway
Ji-Hyun Lee et al.
DIABETES (2009)
SIRT1 Controls the Transcription of the Peroxisome Proliferator-activated Receptor-γ Co-activator-1α (PGC-1α) Gene in Skeletal Muscle through the PGC-1α Autoregulatory Loop and Interaction with MyoD
Ramon Amat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
SIRT1 Exerts Anti-Inflammatory Effects and Improves Insulin Sensitivity in Adipocytes
Takeshi Yoshizaki et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Inflammatory Pathways Are Activated during Cardiomyocyte Hypertrophy and Attenuated by Peroxisome Proliferator-activated Receptors PPARα and PPARδ
Pascal J. H. Smeets et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Sirt1 regulates aging and resistance to oxidative stress in the heart
Ralph R. Alcendor et al.
CIRCULATION RESEARCH (2007)
Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1α
Zachary Gerhart-Hines et al.
EMBO JOURNAL (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Sirtuins as potential targets for metabolic syndrome
Leonard Guarente
NATURE (2006)
Nuclear factor-κB activation leads to down-regulation of fatty acid oxidation during cardiac hypertrophy
A Planavila et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
JT Rodgers et al.
NATURE (2005)
Peroxisome proliferator-activated receptor β/δ activation inhibits hypertrophy in neonatal rat cardiomyocytes
A Planavila et al.
CARDIOVASCULAR RESEARCH (2005)
Silent information regulator 2α, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes
RR Alcendor et al.
CIRCULATION RESEARCH (2004)
Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-γ
F Picard et al.
NATURE (2004)
Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase
F Yeung et al.
EMBO JOURNAL (2004)
NF-κB activation is required for the development of cardiac hypertrophy in vivo
YH Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Peroxisome proliferator activated receptor (PPAR)α agonists inhibit hypertrophy of neonatal rat cardiac myocytes
FQ Liang et al.
ENDOCRINOLOGY (2003)
Activation of nuclear factor-κB is necessary for myotrophin-induced cardiac hypertrophy
S Gupta et al.
JOURNAL OF CELL BIOLOGY (2002)
Involvement of reactive oxygen species-mediated NF-κB activation in TNF-α-induced cardiomyocyte hypertrophy
Y Higuchi et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Involvement of nuclear factor-κB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy
S Hirotani et al.
CIRCULATION (2002)
Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes
NH Purcell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A novel mouse model of lipotoxic cardiomyopathy
HC Chiu et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Share Paper
